Home > Insider Trading > Filing (0001567619-19-022828)

Filing Details

Accession Number:: 0001567619-19-022828
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-12-10 16:19:51
Reporting Period:: 2019-12-06

Accepted Time:: 2019-12-10 16:19:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
722723	Hanger Inc.	HGR	Services-Specialty Outpatient Facilities, Nec (8093)	840904275

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1651089	B. Gabrielle Adams	10910 Domain Drive, Suite 300 Austin TX 78758	Vice President Accounting	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-12-06	10,000	$12.77	49,580	No	4	M	Direct
Common Stock	Disposition	2019-12-06	10,000	$26.81	39,580	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (right to buy)	Disposition	2019-12-06	10,000	$0.00	10,000	$12.77

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,938		2027-05-19	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Performance Share Units	$0.00		2020-05-19	12,375	12,375	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2020-05-19	12,375	12,375	Direct

Footnotes

The price in Column 4 is a weighted average price. The prices actually received ranged from $26.77 to $26.88. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
Includes (i) unvested restricted shares totaling 4,567 shares of stock from an initial grant of 4,567 shares of restricted stock that begins to vest on March 8, 2020; (ii) unvested restricted shares and fully vested shares totaling 4,054 shares of stock from an initial grant of 4,435 shares of restricted stock made on March 9, 2018; (iii) unvested restricted shares and fully vested shares totaling 5,095 shares of stock from an initial grant of 5,574 shares of restricted stock made on March 9, 2018; (iv) unvested restricted shares and fully vested shares totaling 7,266 shares of stock from an initial grant of 7,950 shares of restricted stock made on March 8, 2017;[continued in next footnote]
(v) unvested restricted shares and fully vested shares totaling 2,742 shares of stock from an initial grant of 3,000 shares of restricted stock made on October 11, 2016; (vi) unvested restricted shares and fully vested shares totaling 6,981 shares of stock from an initial grant of 7,750 shares of restricted stock made on April 29, 2016; (vii) fully vested shares which total 3,020 shares of stock from an initial grant of 3,305 shares of restricted stock made on November 10, 2015; [continued in next footnote]
(viii) fully vested shares which total 2,037 shares of stock from an initial grant of 2,229 shares of restricted stock made on September 8, 2015; and (ix) fully vested shares which total 3,818 shares of stock from an initial grant of 4,239 shares of restricted stock made on March 6, 2015.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.
Performance share units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number.